| Dr Teresa Damian Borja, DPM | |
|
122 Tun Jose Toves Way, Tamuning, GU 96913-3507 | |
| (671) 649-3338 | |
| (671) 649-3336 |
| Full Name | Dr Teresa Damian Borja |
|---|---|
| Gender | Female |
| Speciality | Podiatry |
| Experience | 26 Years |
| Location | 122 Tun Jose Toves Way, Tamuning, Guam |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558338509 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0131X | Podiatrist - Foot Surgery | POD000005 (Guam) | Secondary |
| 213ES0131X | Podiatrist - Foot Surgery | POD-05 (Guam) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Guam Memorial Hospital Authority | Tamuning, GU | Hospital |
| Provider Name | Guam Memorial Hospital |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1366519027 PECOS PAC ID: 5890781694 Enrollment ID: O20040426000038 |
News Archive
While many football helmet and mouth guard manufacturers claim that their equipment will lessen impact forces and reduce concussion risk, neither a specific brand nor a higher cost were associated with fewer concussions in adolescent athletes, according to an abstract presented Monday, Oct. 28 at the American Academy of Pediatrics (AAP) National Conference and Exhibition in Orlando.
New research shows that children with an inherited genetic defect in a critical anti-inflammatory pathway have a genetic predisposition to lymphoma. Results of the study, published online today in Blood, the Journal of the American Society of Hematology (ASH), reveal an important association between the genetic defect, which causes chronic intestinal inflammation and early onset inflammatory bowel disease, and its role in cancer development in infants and children.
Advanced Biological Laboratories S.A (ABL) and Evivar Medical Pty Ltd (Evivar) today announced the completion of agreements to cross-licence their respective intellectual property portfolios, and to form strategic alliances based on the use of their proprietary disease management platforms in HIV and Hepatitis B.
Cerus Corporation today announced the pricing of an underwritten public offering of 7,368,422 units, with each unit consisting of one share of its common stock and a warrant to purchase 0.5 of a share of its common stock, at a price to the public of $2.85 per unit. The aggregate public offering price of this offering is approximately $21.0 million, and the net proceeds to the Company, after deducting underwriting discounts and commissions, but before legal and other estimated offering expenses, are expected to be approximately $19.7 million.
› Verified 7 days ago
| Provider Name | Marianas Footcare Clinic |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1093912495 PECOS PAC ID: 1658583455 Enrollment ID: O20150313000931 |
News Archive
While many football helmet and mouth guard manufacturers claim that their equipment will lessen impact forces and reduce concussion risk, neither a specific brand nor a higher cost were associated with fewer concussions in adolescent athletes, according to an abstract presented Monday, Oct. 28 at the American Academy of Pediatrics (AAP) National Conference and Exhibition in Orlando.
New research shows that children with an inherited genetic defect in a critical anti-inflammatory pathway have a genetic predisposition to lymphoma. Results of the study, published online today in Blood, the Journal of the American Society of Hematology (ASH), reveal an important association between the genetic defect, which causes chronic intestinal inflammation and early onset inflammatory bowel disease, and its role in cancer development in infants and children.
Advanced Biological Laboratories S.A (ABL) and Evivar Medical Pty Ltd (Evivar) today announced the completion of agreements to cross-licence their respective intellectual property portfolios, and to form strategic alliances based on the use of their proprietary disease management platforms in HIV and Hepatitis B.
Cerus Corporation today announced the pricing of an underwritten public offering of 7,368,422 units, with each unit consisting of one share of its common stock and a warrant to purchase 0.5 of a share of its common stock, at a price to the public of $2.85 per unit. The aggregate public offering price of this offering is approximately $21.0 million, and the net proceeds to the Company, after deducting underwriting discounts and commissions, but before legal and other estimated offering expenses, are expected to be approximately $19.7 million.
› Verified 7 days ago
| Provider Name | Guam Healthcare Development Incorporated |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1326447939 PECOS PAC ID: 9234351776 Enrollment ID: O20150326000266 |
News Archive
While many football helmet and mouth guard manufacturers claim that their equipment will lessen impact forces and reduce concussion risk, neither a specific brand nor a higher cost were associated with fewer concussions in adolescent athletes, according to an abstract presented Monday, Oct. 28 at the American Academy of Pediatrics (AAP) National Conference and Exhibition in Orlando.
New research shows that children with an inherited genetic defect in a critical anti-inflammatory pathway have a genetic predisposition to lymphoma. Results of the study, published online today in Blood, the Journal of the American Society of Hematology (ASH), reveal an important association between the genetic defect, which causes chronic intestinal inflammation and early onset inflammatory bowel disease, and its role in cancer development in infants and children.
Advanced Biological Laboratories S.A (ABL) and Evivar Medical Pty Ltd (Evivar) today announced the completion of agreements to cross-licence their respective intellectual property portfolios, and to form strategic alliances based on the use of their proprietary disease management platforms in HIV and Hepatitis B.
Cerus Corporation today announced the pricing of an underwritten public offering of 7,368,422 units, with each unit consisting of one share of its common stock and a warrant to purchase 0.5 of a share of its common stock, at a price to the public of $2.85 per unit. The aggregate public offering price of this offering is approximately $21.0 million, and the net proceeds to the Company, after deducting underwriting discounts and commissions, but before legal and other estimated offering expenses, are expected to be approximately $19.7 million.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Teresa Damian Borja, DPM Po Box 7702, Tamuning, GU 96931 Ph: (671) 649-3338 | Dr Teresa Damian Borja, DPM 122 Tun Jose Toves Way, Tamuning, GU 96913-3507 Ph: (671) 649-3338 |
News Archive
While many football helmet and mouth guard manufacturers claim that their equipment will lessen impact forces and reduce concussion risk, neither a specific brand nor a higher cost were associated with fewer concussions in adolescent athletes, according to an abstract presented Monday, Oct. 28 at the American Academy of Pediatrics (AAP) National Conference and Exhibition in Orlando.
New research shows that children with an inherited genetic defect in a critical anti-inflammatory pathway have a genetic predisposition to lymphoma. Results of the study, published online today in Blood, the Journal of the American Society of Hematology (ASH), reveal an important association between the genetic defect, which causes chronic intestinal inflammation and early onset inflammatory bowel disease, and its role in cancer development in infants and children.
Advanced Biological Laboratories S.A (ABL) and Evivar Medical Pty Ltd (Evivar) today announced the completion of agreements to cross-licence their respective intellectual property portfolios, and to form strategic alliances based on the use of their proprietary disease management platforms in HIV and Hepatitis B.
Cerus Corporation today announced the pricing of an underwritten public offering of 7,368,422 units, with each unit consisting of one share of its common stock and a warrant to purchase 0.5 of a share of its common stock, at a price to the public of $2.85 per unit. The aggregate public offering price of this offering is approximately $21.0 million, and the net proceeds to the Company, after deducting underwriting discounts and commissions, but before legal and other estimated offering expenses, are expected to be approximately $19.7 million.
› Verified 7 days ago
Teresa D Borja, Dpm Podiatrist Medicare: Medicare Enrolled Practice Location: 425 Chalan San Antonio, Pmb 1021, Tamuning, GU 96913 Phone: 671-649-3338 Fax: 671-649-3336 | |
Dustin B Prins, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 122 Tun Jose Toves Way, Tamuning, GU 96913 Phone: 671-649-3338 | |
Dr. Maria Melinda Bernales Sangalang, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 633 Gov Carlos G Camacho Rd, Suite 212, Tamuning, GU 96913 Phone: 671-646-3375 Fax: 671-649-2266 |